More frequent glucose monitoring during the switch helps detect any destabilization early
Patients should never double up on doses or take extra medication to compensate for missed doses, as this increases the risk of adverse effects without providing additional therapeutic benefit
The GLP-1 biosimilars market is gaining significant momentum, driven by the global surge in obesity and type 2 diabetes prevalence, escalating healthcare costs, and the growing need for accessible treatment options
Gastrointestinal side effects appear to be more pronounced in oral formulations, while injectable administration can cause injection site irritation [14]
(PubMed) Huang K, Duan HQ, Li QX, Luo YB, Yang H
The category implication of all this is bigger than any individual operators earnings beat